+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antiemetic Drugs Market - Global Forecast 2026-2032- Product Image
Antiemetic Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Antiemetic Drugs Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924704
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antiemetic Drugs Market is projected to reach USD 9.22 Billion in 2026. It is expected to continue growing at a CAGR of 6.12%, reaching USD 13.21 Billion by 2032.

Antiemetic drugs are medicines used to prevent or treat nausea and vomiting associated with conditions such as chemotherapy, surgery, pregnancy, motion sickness, migraine, gastrointestinal illness, and medication use. The market spans several pharmacological classes, including serotonin receptor antagonists, dopamine antagonists, neurokinin receptor antagonists, antihistamines, anticholinergics, and cannabinoid-based therapies. Demand is shaped by the incidence of underlying conditions, clinical treatment protocols, regulatory requirements, prescribing practices, patient preferences, and access to healthcare.

Transformative Shifts Reshaping Antiemetic Drug Use

Clinical practice is moving toward more individualized prevention and treatment of nausea and vomiting. Regimens are increasingly selected according to the emetogenic risk of therapy, patient characteristics, prior response, and potential drug interactions. Greater attention to delayed symptoms, breakthrough episodes, adherence, and supportive care is also encouraging combination approaches and alternative dosage forms, including oral dissolving, injectable, transdermal, and long-acting options. Generic competition, hospital formulary controls, safety monitoring, and efforts to improve access continue to influence product selection across care settings.

How Artificial Intelligence Is Influencing Antiemetic Care

Artificial intelligence can support antiemetic care by identifying patients at elevated risk of nausea and vomiting, analyzing treatment and medication histories, and helping clinicians select prophylactic regimens. Predictive tools may also assist with symptom monitoring, adherence support, adverse-event detection, and prioritization of follow-up. However, clinical usefulness depends on representative data, external validation, transparent decision logic, privacy safeguards, and integration into prescribing workflows. AI should complement, rather than replace, evidence-based guidelines and professional judgment.

Regional Insights Across Antiemetic Drug Use

North America is characterized by advanced oncology, surgical, and ambulatory care infrastructure, broad use of guideline-based supportive therapies, and strong attention to medication safety and reimbursement. Europe combines established clinical protocols with national health-system assessment, generic substitution, and varying access conditions across countries. Asia-Pacific includes mature pharmaceutical systems alongside rapidly expanding healthcare capacity, creating diverse needs across Japan, Australia, China, India, and other markets. Latin America is influenced by unequal access, public-sector procurement, and the availability of affordable formulations. The Middle East shows differing levels of specialist care, import dependence, and hospital investment, while Africa faces substantial challenges involving diagnosis, supply continuity, affordability, and healthcare workforce capacity.

Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members have diverse regulatory systems and healthcare resources, making affordability, local registration, supply reliability, and hospital access important considerations. BRICS economies combine large and varied patient populations with growing domestic pharmaceutical capabilities, but access and treatment consistency differ substantially among members. The European Union emphasizes harmonized regulatory standards while retaining national differences in reimbursement and procurement. G7 countries generally have sophisticated clinical infrastructure, extensive pharmacovigilance, and established supportive-care pathways. GCC states benefit from concentrated healthcare investment and specialist facilities, although procurement and import dynamics remain relevant. NATO members span varied health systems, with emergency preparedness, resilient supply chains, and continuity of essential medicines representing shared priorities.

Country Insights: Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, UK, and US

Australia combines universal healthcare structures with established hospital and oncology services, while Brazil and Mexico continue to navigate regional disparities and public-versus-private access differences. Canada’s geography and provincial purchasing arrangements affect availability and care pathways. China is expanding sophisticated hospital and pharmaceutical capabilities, while India combines strong generic manufacturing capacity with uneven access across states. Japan and South Korea emphasize advanced hospital care and clinical protocol adherence. France, Germany, Italy, and Spain operate within mature European systems, but reimbursement, procurement, and prescribing practices vary. The United Kingdom relies on national guidance and health-system procurement. The United States has extensive specialist care and product choice, alongside complex payer and formulary dynamics. Russia’s access is shaped by domestic production, procurement policy, and healthcare-system conditions.

Actionable Priorities for Antiemetic Drug Industry Leaders

Industry leaders should align product development with clearly defined clinical gaps, including delayed and breakthrough nausea, pediatric and geriatric use, polypharmacy, and administration outside hospitals. Evidence generation should address comparative effectiveness, real-world adherence, safety, and outcomes relevant to payers and health systems. Portfolio planning should balance innovative formulations with reliable access to essential medicines, while supply-chain strategies should include diversified manufacturing, quality controls, and contingency planning. Digital and AI-enabled tools should be introduced with clinical validation, cybersecurity protections, and workflow integration. Regional strategies should reflect local regulatory requirements, procurement structures, affordability constraints, and professional education needs.

Research Methodology for the Antiemetic Drugs Assessment

This executive summary uses a structured qualitative assessment of the antiemetic drugs landscape. The analysis organizes evidence around therapeutic applications, drug classes, care settings, regulatory and reimbursement conditions, access factors, clinical practice, supply considerations, and technology adoption. Regional, group, and country comparisons are based on publicly documented healthcare-system characteristics, treatment patterns, policy environments, and pharmaceutical infrastructure. Interpretations are limited to verifiable structural insights and deliberately exclude market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Building More Accessible and Personalized Antiemetic Care

The antiemetic drugs landscape is being shaped by the need for reliable symptom prevention, individualized treatment, safer combination therapy, and broader access across diverse healthcare systems. Clinical protocols, formulation innovation, generic availability, supply resilience, and digital decision support will remain important areas of development. Organizations that combine robust evidence with responsible technology use, dependable manufacturing, and region-specific access strategies will be better positioned to support patients and healthcare professionals across oncology, surgery, pregnancy care, and other settings where nausea and vomiting affect outcomes and quality of life.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Antiemetic Drugs Market, by Drug Class
7.1. Introduction
7.2. Corticosteroids
7.3. Dopamine Antagonists
7.4. Neurokinin 1 Receptor Antagonists
7.5. Serotonin 5-HT3 Receptor Antagonists
8. Antiemetic Drugs Market, by Indication
8.1. Introduction
8.2. Chemotherapy-Induced Nausea And Vomiting
8.3. Post-Operative Nausea And Vomiting
8.4. Radiation-Induced Nausea And Vomiting
9. Antiemetic Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Intravenous
9.3. Oral
10. Antiemetic Drugs Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care Settings
10.4. Hospitals
11. Antiemetic Drugs Market, by Molecule Type
11.1. Introduction
11.2. Small Molecule Drugs
11.3. Biologic Drugs
11.4. Cannabinoid Based Drugs
12. Antiemetic Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Antiemetic Drugs Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. Europe
13.4. North America
13.5. Latin America
13.6. Africa
13.7. Middle East
14. Antiemetic Drugs Market, by Group
14.1. Introduction
14.2. NATO
14.3. G7
14.4. BRICS
14.5. European Union
14.6. ASEAN
14.7. GCC
15. Antiemetic Drugs Market, by Country
15.1. Introduction
15.2. China
15.3. United States
15.4. Japan
15.5. India
15.6. Germany
15.7. United Kingdom
15.8. Australia
15.9. France
15.10. South Korea
15.11. Italy
15.12. Canada
15.13. Russia
15.14. Brazil
15.15. Mexico
15.16. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Alkem Laboratories Limited
17.3. Amgen Inc
17.4. Astellas Pharma Inc
17.5. AstraZeneca PLC
17.6. Aurobindo Pharma Limited
17.7. Baxter International Inc
17.8. Boehringer Ingelheim International GmbH
17.9. Cipla Limited
17.10. Dr Reddys Laboratories Limited
17.11. Eagle Pharmaceuticals Inc
17.12. Eisai Co Ltd
17.13. Eli Lilly and Company
17.14. F Hoffmann-La Roche Ltd
17.15. Fresenius Kabi AG
17.16. Glenmark Pharmaceuticals Limited
17.17. GSK plc
17.18. Hikma Pharmaceuticals PLC
17.19. Johnson & Johnson
17.20. Lupin Limited
17.21. Merck & Co Inc
17.22. Novartis AG
17.23. Pfizer Inc
17.24. Sun Pharmaceutical Industries Limited
17.25. Takeda Pharmaceutical Company Limited
17.26. Teva Pharmaceutical Industries Limited
17.27. Torrent Pharmaceuticals Limited
17.28. Viatris Inc
17.29. Zydus Lifesciences Limited
18. Key Experts
List of Figures
FIGURE 1. Global Antiemetic Drugs Market, Years Considered for the Study
FIGURE 2. Global Antiemetic Drugs Market, Research Design
FIGURE 3. Global Antiemetic Drugs Market, Research Framework
FIGURE 4. Global Antiemetic Drugs Market, Data Triangulation
FIGURE 5. Global Antiemetic Drugs Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Antiemetic Drugs Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 7. Global Antiemetic Drugs Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Antiemetic Drugs Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Antiemetic Drugs Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Antiemetic Drugs Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Antiemetic Drugs Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Antiemetic Drugs Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Antiemetic Drugs Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Antiemetic Drugs Market Size, by Molecule Type, 2025 vs 2032 (%)
FIGURE 15. Global Antiemetic Drugs Market Size, by Molecule Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Antiemetic Drugs Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Antiemetic Drugs Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Antiemetic Drugs Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Antiemetic Drugs Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Antiemetic Drugs Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Antiemetic Drugs Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Antiemetic Drugs Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Antiemetic Drugs Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Antiemetic Drugs Market Segmentation & Coverage
TABLE 2. Global Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 3. Global Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 4. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Dopamine Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Dopamine Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Dopamine Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Neurokinin 1 Receptor Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Neurokinin 1 Receptor Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Neurokinin 1 Receptor Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Serotonin 5-HT3 Receptor Antagonists Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Serotonin 5-HT3 Receptor Antagonists Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Serotonin 5-HT3 Receptor Antagonists Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 17. Global Chemotherapy-Induced Nausea And Vomiting Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Chemotherapy-Induced Nausea And Vomiting Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Chemotherapy-Induced Nausea And Vomiting Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Post-Operative Nausea And Vomiting Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Post-Operative Nausea And Vomiting Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Post-Operative Nausea And Vomiting Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Radiation-Induced Nausea And Vomiting Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Radiation-Induced Nausea And Vomiting Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Radiation-Induced Nausea And Vomiting Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 27. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 34. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 44. Global Small Molecule Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Small Molecule Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Small Molecule Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Biologic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Biologic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Biologic Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Cannabinoid Based Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Cannabinoid Based Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Cannabinoid Based Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 54. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Antiemetic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Antiemetic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 68. Europe Antiemetic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Europe Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 70. Europe Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 71. Europe Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 72. Europe Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Europe Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 74. Europe Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. North America Antiemetic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. North America Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 77. North America Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 78. North America Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 79. North America Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. North America Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 81. North America Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 82. Latin America Antiemetic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Latin America Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 84. Latin America Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 85. Latin America Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 86. Latin America Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Latin America Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 88. Latin America Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Africa Antiemetic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Africa Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 91. Africa Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 92. Africa Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 93. Africa Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Africa Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 95. Africa Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Middle East Antiemetic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Middle East Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 98. Middle East Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 99. Middle East Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 100. Middle East Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Middle East Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 102. Middle East Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. Global Antiemetic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. NATO Antiemetic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. NATO Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 106. NATO Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 107. NATO Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 108. NATO Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. NATO Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 110. NATO Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. G7 Antiemetic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. G7 Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 113. G7 Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 114. G7 Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 115. G7 Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. G7 Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 117. G7 Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. BRICS Antiemetic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. BRICS Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 120. BRICS Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 121. BRICS Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 122. BRICS Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. BRICS Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 124. BRICS Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. European Union Antiemetic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. European Union Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 127. European Union Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 128. European Union Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 129. European Union Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. European Union Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 131. European Union Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. ASEAN Antiemetic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 134. ASEAN Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 135. ASEAN Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 136. ASEAN Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. ASEAN Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. GCC Antiemetic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. GCC Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 141. GCC Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. GCC Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 143. GCC Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. GCC Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 145. GCC Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Global Antiemetic Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. China Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 148. China Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 149. China Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 150. China Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 151. China Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. China Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 153. China Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 154. United States Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 155. United States Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 156. United States Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 157. United States Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. United States Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. United States Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 160. United States Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. Japan Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 162. Japan Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 163. Japan Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 164. Japan Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 165. Japan Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Japan Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 167. Japan Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 168. India Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 169. India Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 170. India Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 171. India Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 172. India Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. India Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 174. India Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Germany Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 176. Germany Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 177. Germany Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 178. Germany Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 179. Germany Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Germany Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 181. Germany Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. United Kingdom Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 183. United Kingdom Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 184. United Kingdom Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 185. United Kingdom Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 186. United Kingdom Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. United Kingdom Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 188. United Kingdom Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Australia Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 190. Australia Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 191. Australia Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 192. Australia Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 193. Australia Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Australia Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 195. Australia Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. France Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 197. France Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 198. France Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 199. France Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 200. France Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. France Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 202. France Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. South Korea Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 204. South Korea Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 205. South Korea Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 206. South Korea Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 207. South Korea Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. South Korea Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 209. South Korea Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. Italy Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 211. Italy Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 212. Italy Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 213. Italy Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 214. Italy Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Italy Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 216. Italy Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. Canada Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 218. Canada Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 219. Canada Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 220. Canada Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 221. Canada Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Canada Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 223. Canada Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Russia Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 225. Russia Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 226. Russia Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 227. Russia Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 228. Russia Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Russia Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 230. Russia Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. Brazil Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 232. Brazil Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 233. Brazil Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 234. Brazil Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 235. Brazil Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Brazil Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 237. Brazil Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. Mexico Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 239. Mexico Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 240. Mexico Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 241. Mexico Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 242. Mexico Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Mexico Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 244. Mexico Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. Spain Antiemetic Drugs Market Size, 2017-2032 (USD Million)
TABLE 246. Spain Antiemetic Drugs Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 247. Spain Antiemetic Drugs Market Size, by Indication, 2017-2032 (USD Million)
TABLE 248. Spain Antiemetic Drugs Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 249. Spain Antiemetic Drugs Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Spain Antiemetic Drugs Market Size, by Molecule Type, 2017-2032 (USD Million)
TABLE 251. Spain Antiemetic Drugs Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. Global Antiemetic Drugs Market Share, by Key Player, 2025
TABLE 253. Global Antiemetic Drugs Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alkem Laboratories Limited
  • Amgen Inc
  • Astellas Pharma Inc
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Baxter International Inc
  • Boehringer Ingelheim International GmbH
  • Cipla Limited
  • Dr Reddys Laboratories Limited
  • Eagle Pharmaceuticals Inc
  • Eisai Co Ltd
  • Eli Lilly and Company
  • F Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Glenmark Pharmaceuticals Limited
  • GSK plc
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Limited
  • Torrent Pharmaceuticals Limited
  • Viatris Inc
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages197
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.22 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.21 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Antiemetic Drugs - Global Strategic Business Report - Product Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • 204 Pages
  • Global
From
Antiemetics and Antinauseants Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Antiemetics and Antinauseants Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Antiemetic Drugs Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Type, Application, Route of Administration, Distribution Channel - Product Image

Antiemetic Drugs Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Type, Application, Route of Administration, Distribution Channel

  • Report
  • 160 Pages
  • Global
From
Antiemetics and Antinauseants Market Report 2026 - Product Image

Antiemetics and Antinauseants Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Global Antiemetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Global Antiemetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From

About the Antiemetic Market

The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids. The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.